DexCom (DXCM) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.76 -1.1%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.04), $0.12 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $184.6 million versus the consensus estimate of $184.22 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- XP Inc eyes US banking license as next business step
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
